Inmed Pharmaceuticals Inc (INM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 12-2019 | 09-2019 | 06-2019 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 0 | 0 | 9,837 |
| Marketable Securities | 0 | 0 | 3,947 |
| Receivables | 0 | 0 | 65 |
| Other current assets | 0 | 0 | 324 |
| TOTAL | $0 | $0 | $14,173 |
| Non-Current Assets | |||
| PPE Net | N/A | N/A | 96 |
| Other Non-Current Assets | 0 | 0 | 1,221 |
| TOTAL | $N/A | $N/A | $1,317 |
| Total Assets | $0 | $0 | $15,437 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 0 | 0 | 1,194 |
| TOTAL | $0 | $0 | $1,194 |
| Non-Current Liabilities | |||
| TOTAL | $N/A | $N/A | $N/A |
| Total Liabilities | $0 | $0 | $1,194 |
| Shareholders' Equity | |||
| Common Shares | 0 | 0 | 53,065 |
| Retained earnings | 0 | 0 | -55,710 |
| Other shareholders' equity | 0 | 0 | 118 |
| TOTAL | $0 | $0 | $14,243 |
| Total Liabilities And Equity | $0 | $0 | $15,437 |